Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: China Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20125
20141
20152
20163
20171
20181
20196
20209
20217
20222
20234
20246
20251
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status29
Completed11
Recruiting10
Active, not recruiting3
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University9
Sun Yat-sen University9
Zhejiang Cancer Hospital4
Betta Pharmaceuticals Co., Ltd.2
Chinese Academy of Medical Sciences2
Guangzhou Medical University2
Li-kun Chen2
TYK Medicines, Inc2
BioNTech SE1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms56
Carcinoma, Non-Small-Cell Lung23
Breast Neoplasms8
Lung Neoplasms4
Glioblastoma3
Meningeal Carcinomatosis3
Glioma2
Melanoma2
Pancreatic Neoplasms2
Adenocarcinoma of Lung1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.